Navigation Links
Sangamo BioSciences Reports First Quarter 2013 Financial Results
Date:5/8/2013

BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS.
Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and  hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function.
Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia, Huntington's disease and other monogenic diseases and has established strategic partnerships with companies in non-therapeutic applications of its technology including Dow AgroSciences and Sigma-Aldrich Corporation. For more information about Sangamo, visit the company's website at www.sangamo.com.

ZFP Therapeutic® is a registered trademark of Sangamo BioSciences, Inc.

This press release contains forward-looking statements regarding Sangamo's current expectations.  These forward looking statements include, without limitation, references to anticipated year-end cash and investments, operating expenses and revenues from agreements, the research and development of ZFP TFs and ZFNs, achievement of research milestones and objectives, clinical trials and therapeutic applications of Sangamo's ZFP technology platform and expected timing for the presentation of data from clinical trials. Thes
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sangamo BioSciences Reports Second Quarter 2012 Financial Results
2. Sangamo BioSciences to Webcast Analyst Briefing on Thursday, December 6, 2012
3. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
4. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
5. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
6. Sangamo BioSciences Announces First Quarter 2013 Conference Call and Webcast
7. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
8. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
9. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
10. Neurocrine Biosciences Reports First Quarter 2012 Results
11. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... -- Market research firm Kalorama information says that 2014 will ... the medical device industry.  The firm thinks the $360 ... 3% growth this year, which led firms to look ... and entrance by acquisition into new competitive zones.  The ... The Global Market for Medical Devices, 5 th ...
(Date:11/21/2014)... , 21. November 2014 Michael ... sich am Morgen des 14. Februar 2014 zugetragen hat. ... wohl kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... ich dabei war, mein morgendliches Training zu machen", erzählt ... zu der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. ...
(Date:11/21/2014)...  Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ) ... public offering of $50,000,000 of shares of its common ... offering will consist of 49,751,244 shares of common stock ...  Lexicon has also granted the underwriters a 30-day option ... stock.  All of the shares in the offering will ...
Breaking Medicine Technology:Kalorama: 2014 The "Year of The Buy" in Medical Device Industry 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3
... Japan, April 15, 2011 Takeda Pharmaceutical Company Limited ... today announced that EDARBI (azilsartan medoxomil), an angiotensin II ... or high blood pressure, is now available by prescription ... Drug Administration (FDA) approved EDARBI on February 25, 2011 ...
... 2011 Theramed Corporation ("Theramed") announces that it ... for the EBB® Complete Tamponade System and the ... devices used to advance the practice of obstetrics, ... medical device products have been approved for sale ...
Cached Medicine Technology:EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension 2EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension 3EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension 4EDARBI (azilsartan medoxomil), Now Available in U.S. Pharmacies for Patients With Hypertension 5Theramed Secures Exclusive Canadian Distribution Rights for Two Novel Obstetrics Products from Glenveigh 2
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, offering ... “If you are looking for gorgeous beach wedding dresses ... Here you can enjoy 70% off discounts and all ... big marriage ceremony is the most important dream of ... is uppermost priority. Ophelia, one of customers, said, “I ...
(Date:11/23/2014)... Wright & Schulte LLC recently filed 40 C8 ... residents who allege that they developed thyroid disease, high ... C8 contaminated water released by the DuPont Washington ... C8 complaints, the plaintiffs were exposed to the C8 ... least one of the six water districts affected by ...
(Date:11/22/2014)... Cancer researchers in New York and Minnesota believe ... and the growth and spread of mesothelioma. Click ... Surviving Mesothelioma website. , Doctors at Memorial Sloan ... just released their study on tunneling nanotubes (TnTs), actin-based ... found that mesothelioma cells contain many more ...
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in the bamboo ... collection of bamboo mats ; the new models are ... , According to the sales manager of BambooFlooringChina.com, Bamboo ... highly renewable resource. Their bamboo mats are 100% made from ... from natural bamboo with caramel bamboo strips. , ...
(Date:11/22/2014)... 22, 2014 In order to provide better ... of cocktail party dresses. The business knows that a suitable ... occasions. , Now, the party dresses supplier’s high ... off. As the leading company in fashion industry, LunaDress understands ... for every customer. So it always raises the professional level ...
Breaking Medicine News(10 mins):Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2
... of Oregon Health & Science University, received a research ... (NTI) to study a method that could more accurately ... ill or obese trauma patients. Schreiber,s study is ... NTI, a nonprofit organization dedicated to funding trauma research ...
... (ESMO), the leading professional organization for medical oncology ... been included among the medical specialties covered by ... as announced yesterday by the Commission. The decision ... between ESMO, key national societies and EU Member ...
... radiation inside a tumour using,boron-10 and thermal neutrons. Boron-10 ... a special carrier substance (phenylalanine), after which the tumour ... the boron to generate high-LET radiation, which may destroy ... may be sufficient to destroy a tumour, while keeping ...
... , FRIDAY, March 4 (HealthDay News) -- ... they have good parks and playgrounds in their neighborhoods, ... of 171 nine-year-old children to give their opinions about ... the amount of time their children spent watching television, ...
... (HealthDay News) -- An analysis of breast tissue may help ... new study reports. Researchers analyzed what they describe as ... that the way collagen fibers -- the main component of ... diagnosis and help determine treatment. Collagen not only surrounds ...
... (ASM) will hold its 111th General Meeting May ... meeting will feature approximately 3,000 individual scientific presentations ... expected attendance of 10,000. Microbiologists study living ... critical to human and animal health, agriculture, the ...
Cached Medicine News:Health News:BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer 2Health News:Tissue Analysis May Help Predict Breast Cancer Outcome 2Health News:American Society for Microbiology to host 111th General Meeting in New Orleans 2
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: